Andrei Iagaru, MD

Andrei Iagaru, MD, is professor of radiology at Stanford University. He has published more than 245 peer-reviewed articles and book chapters and has received numerous national and international honors for contributions to nuclear medicine and molecular imaging, including recognition from the Society of Nuclear Medicine and Molecular Imaging. He helped build Stanford's dedicated theranostics clinic from initial planning in 2013 through its 2021 opening, and serves as a close clinical and research collaborator with Stanford's genitourinary and gastrointestinal medical oncology programs on radioligand therapy trials, including as co-investigator on the VISION trial that led to the first PSMA-targeted radioligand approval.